Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
NCT06408584 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2024-05-21
Summary
The goal of this observational study was to explore the safety and efficacy of short course hypofractionated radiotherapy combined with Raltitrexed and Tislelizumab in the treatment of patients with relapsed or advanced esophageal squamous cell carcinoma.
Conditions
Sponsors & Collaborators
-
Anhui Provincial Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-01
- Primary Completion
- 2027-03-01
- Completion
- 2027-03-01
Countries
- China
Study Locations
More Related Trials
-
Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
NCT05984342 ·Status: RECRUITING ·Phase: PHASE1
-
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
NCT06603402 ·Status: RECRUITING ·Phase: PHASE2
-
Tislelizumab Combined with Chemotherapy and All Trans Retinoic Acid for Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
NCT06703047 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma
NCT06446726 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma
NCT02570893 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
NCT06468644 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Raltitrexed Concurrent With Radiotherapy for Elderly Chinese Patients With Squamous Cell Carcinoma of Esophagus
NCT03585530 ·Status: UNKNOWN ·Phase: PHASE2
-
Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer
NCT05628610 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer
NCT06430658 ·Status: RECRUITING ·Phase: PHASE2
-
Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma
NCT06468670 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
IMRT With Carboplatin Versus IMRT With Carboplatin and Fluorouracil for Eldly Esophageal Cancer Patients
NCT03910634 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Comparing Huachansu Plus Thoracic RT Versus RT Alone For ESCC
NCT02647125 ·Status: COMPLETED ·Phase: PHASE2
-
Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma
NCT06122493 ·Status: RECRUITING ·Phase: PHASE2
-
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
NCT03790553 ·Status: UNKNOWN ·Phase: PHASE3
-
Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma
NCT06303583 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2
-
The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC
NCT06965829 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Neoadjuvant Immunotherapy Plus CRT Versus Neoadjuvant CRT for Locally Advanced Resectable ESCC
NCT04973306 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
NCT00154804 ·Status: COMPLETED ·Phase: PHASE2
-
Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for Esophageal Squamous Cell Carcinoma
NCT07188103 ·Status: RECRUITING ·Phase: PHASE2
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
NCT03600831 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
NCT07182565 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
NCT06602843 ·Status: RECRUITING ·Phase: NA